Postmortem brain tissue was used to measure expression of serotonin transporter mRNA in the left frontal and left temporal cortex from schizophrenics (n ‫؍‬ 24) and from normal control individuals with no history of psychiatric illness (n ‫؍‬ 10). There was an approximately fourfold increase of serotonin transporter mRNA in Brodmann's area 9 and a two-fold decrease in Brodmann's areas 21 and 22. The changes in serotonin transporter mRNA were more prominent in schizophrenics who had received neuroleptic drugs within 1 week prior to death than in schizophrenics who were neuroleptic-free for more than 2 weeks prior to death, suggesting that the changes may be related to neuroleptic treatment. There was no correlation between serotonin transporter mRNA levels and the sex or age of schizophrenic and control cases or the postmortem delay intervals. These results support the hypothesis that region-specific changes in serotonin transporter expression occur in brains of some schizophrenics. Future studies are necessary to determine whether the changes in serotonin transporter expression are drug-related or are associated with the illness itself.
Introduction
changes in 5-HT uptake may be present in the cortex of subjects with schizophrenia. Here we developed a The serotonergic system is known to exert modulatory quantitative RT-PCR assay for mRNA encoding the effects on many behavioral/physiological processes serotonin transporter and examined its expression in that are often disturbed in schizophrenia. [1] [2] [3] [4] Terminleft temporal and left frontal cortices (specifically, left ation of the synaptic action of serotonin (5-HT) and its superior temporal gyrus, left middle temporal gyrus recycling into the neurotransmitter pool is directed by and left superior frontal gyrus, Brodmann's areas 22, 21 the serotonin transporter protein (SERT). [5] [6] [7] Several and 9 respectively) derived from schizophrenics and studies using radioligands that can bind to 5-HT uptake controls. These regions of the brain have been presites have reported regional abnormalities in 5-HT viously implicated in schizophrenia based on funcuptake sites in schizophrenia. [6] [7] [8] [9] [10] [11] For example, intional, anatomical, cellular and biochemical findcreased binding of [ ings. [12] [13] [14] [15] [16] [17] [18] The results here indicate that region-specific to tissue sections and altered striosomal/matrix organichanges in SERT mRNA expression may be present in zation of 5-HT uptake sites in the striatum have been left temporal and left frontal cortices of some schizoreported. 10 A marked reduction in [ The study was performed on postmortem brain speciphrenics 9 and a reduction in the number of [ 3 H]imipramens derived from schizophrenics (n = 24) and normal mine sites in the frontal cortex of the right but not the elderly controls (n = 10), matched for gender and age. left hemisphere of schizophrenics 8 has also been These samples were obtained through the Schizoreported. However, these results have not always phrenia Brain Bank of the Department of Psychiatry at been replicated. remaining 10 cases were based on extensive chart extracted twice with phenol/chloroform/isoamyl alcohol, precipitated by adding an equal amount of isoproreview by the same diagnosis and assessment team. The antemortem assessment battery and assessment panol and washed three times with cold 70% ethanol. procedures have been described in detail previously. 19 One schizophrenic case (No. 265) carried a dual diagReverse transcription Two to 10 g of total RNA were used in 40 l of reverse nosis of schizophrenia and personality disorder (DSMIII-301.90). Nine of the ten normal elderly contranscription reaction to synthesize cDNA using a commercial kit (SuperScript, Gibco BRL, Grand Island, NY, trols were residents of a large nursing home in Manhattan. The remaining control case was a patient at the USA) and random hexanucleotides as primers. Then the cDNA was diluted to a concentration of 0.02 g l
−1
Bronx VA Medical Center at the time of death. The brain specimen collection and handling procedures with water and 0.1-0.25 g of the diluted cDNA was amplified in 15-35 l of PCR reaction. were identical in all the cases studied irrespective of final diagnosis. One of the selection criteria for all of the cases, controls and schizophrenics, was that there
Polymerase chain reaction Amplification of SERT mRNA was performed using was no history of drug or alcohol abuse. Although this is a category for which negative findings are not necesprimers SERT3, 5Ј-CAGCATCTGGAAAGGCGTCAA-GACC-3Ј and SERT4, 5Ј-AGTGGACGCTGGATGsarily definitive in the nursing home population (controls), there is a greater confidence for the schizo-TTGGCTATC-3Ј. The primers were directed to sequences in exon 5 (bases 876 to 901) and exon 9 phrenic cohort who were all chronically institutionalized patients with extensive medical histories (bases 1334 to 1310) of the SERT mRNA 7 and amplified a fragment of 458 bp. The primers were directed to available for review. The majority of cases (31 out of 34) have been found to be free of neuropathological sequences in different exons to make amplification of the genomic SERT sequence impossible under the lesions which could confound interpretation of the experimental results (eg Alzheimer's disease, infarcts, chosen conditions of PCR. The conditions for PCR were: 33 cycles consisting of 94°C for 30 s, 68°C for Lewy body disease, etc). One schizophrenic (No. 123) showed evidence of acute myelocytic leukemia, and 1 min, and 72°C for 1 min in a 9600 (Perkin Elmer) temperature cycler. Amplification of ␤-actin mRNA one case (No. 142) evidenced old cerebrovascular disease with amyloid angiopathy. Evidence of an old was performed using primers BA1, 5Ј-ACGAAAC-TACCTTCAACTCC-3Ј and BA2, 5Ј-CAAAAGCCTTCAinfarct was found in the contralateral temporal cortex of one of the normal elderly controls (No. 109). Exclud-TACATCTC-3Ј. The PCR cycle consisted of 94°C for 30 s, 54°C for 1 min, and 72°C for 1 min. RT-PCR assay ing these three cases from statistical analysis had no significant effect on the results. In the schizophrenic of SERT mRNA abundance as a ratio to ␤-actin mRNA abundance was carried out using a mixture of primers group, 19 patients were whites, three blacks and two hispanics. All control cases were whites. Brain samples SERT1, SERT2, BA1, and BA2 in the same reaction. The conditions for PCR were: 33 cycles consisting of were sectioned in the coronal plane into 5-7 mm thick slabs, snap frozen and stored at −80°C. Approximately 94°C for 30 s, 68°C for 1 min, and 72°C for 1 min. Primers for PCR were 5Ј-end labeled with 32 P. The con-1 cm × 1 cm × 0.5-0.8 cm tissue pieces corresponding to and following the contours of the specific Brodmann centration of each primer in PCR reaction was 1 M. The amplified cDNA fragments were analyzed by cortical areas were sub-dissected using a croll saw maintained in a −20°C freezer. No more than a 1-mm electrophoresis in 6% polyacrylamide gels. The relative intensities of DNA bands were measured using white matter border was included. The sub-dissected blocks were cooled further by immersion into liquid PhosphorImager. The level of expression of the SERT mRNA was normalized to ␤-actin. Assay of each mRNA nitrogen and were then crushed to a fine powder using a liquid nitrogen cooled mortar and pestle and alisample was repeated four or five times. Statistical analysis was carried out using GB-STAT quoted for analysis. All samples were from the left hemispheres. Samples were not available for all cases computer program package (Dynamics Microsystems, Inc, Silver Spring, MD, USA). in all regions.
RNA was isolated from the left superior temporal gyrus, left middle temporal gyrus and left superior Results frontal gyrus (Brodmann's areas 22, 21 and 9 respectively).
Tissue donors
Tissues were collected from 24 subjects with schizophrenia and 10 subjects with no known history of men-RNA isolation Total RNA was isolated from 200 mg of postmortem tal illness. All patients with schizophrenia had been treated with antipsychotic drugs (mostly typical human brain by the guanidinium isothiocyanate method. 20 To remove DNA contamination, the RNA neuroleptics) some time in their lives ( Table 1) . Six patients with schizophrenia were receiving neuroleptic samples were treated with 30 units of DNAse I (5 Prime → 3 Prime, Inc, Boulder, CO, USA) in a 200-l reaction drugs at the time of death or until 72 h prior to death. Three patients were receiving neuroleptics until 1 mixture containing 5 mM MgCl 2 , 30 mM Tris-HCl, pH 7.5; and 100 units of RNase inhibitor (Clontech Laboraweek prior to death. The remaining 15 patients had not been exposed to neuroleptics for between 2 weeks to tories, Inc, Palo Alto, CA, USA) for 1 h at 37°C, Values are mean ± s.d.
years prior to death. The schizophrenic and control
Assay for the serotonin transporter mRNA Preliminary experiments indicated that the level of groups had similar male to female ratios (15/9 and 6/4 respectively). There was no significant difference in SERT mRNA in human cortex was far below the sensitivity of Northern blotting which is in agreement with age between schizophrenics (52-95 years; mean = 74, s.d. = 11.6) and controls (55-96 years; mean = 77, s.d.
the data reported for rat brain. 21 Accordingly, a more sensitive quantitative assay based on reverse transcrip-= 11). The time between death and freezing of the samples [postmortem interval (PMI)] in the control tion followed by PCR was developed. Primers for PCR were designed to amplify a 458-bp fragment of SERT group varied from 3 to 10 h (mean = 5.2, s.d. = 2.3). In the group of schizophrenics PMI varied from 3.5 to cDNA ( Figure 1a ) using published sequence of SERT mRNA. 7 Using 250 ng of total RNA from postmortem 111 h (mean = 44, s.d. = 38) which is significantly higher than in the control group (P Ͻ0.001).
human brain (Brodmann's area 9 and lobule IX of the Figure 2 The kinetics of SERT and ␤-actin mRNA amplification. Reverse transcribed RNA from cerebellum (250 ng) was amplified in PCR using primers specific for SERT (¼) or primers specific for ␤-actin (). Optimal calculated annealing temperature in PCR for SERT primers was 72°C, for ␤-actin primers 54°C. Annealing temperature in PCR reaction was 68°C. The abundance of PCR products was meas- Figure 1 The amplification of SERT mRNA in total RNA ured after electrophoresis in 6% polyacrylamide gel using a from postmortem human brain. (a) Autoradiography of 6% phosphostimulable storage plate (PhosphorImager, Molecupolyacrylamide gel. Two hundred and fifty nanograms of total lar Dynamics). RNA were reverse transcribed and amplified in PCR (33 cycles) as described in Materials and Methods using primers directed to SERT mRNA sequence. Lane 1, control, phrenic brains as compared to control brains, was inde- mRNA in brain was significantly higher than the level of SERT mRNA. Therefore, under optimal conditions amplification of ␤-actin mRNA reached a plateau before SERT mRNA became detectable. To overcome cerebellum) in 35 l of PCR reaction, and primers labeled with 32 P, the band derived from SERT mRNA was this problem, the primers for SERT were designed so as to have an optimal annealing temperature of 68°C, detectable with 30 cycles of amplification or more. No SERT was amplified from RNA isolated from human whereas the primers for ␤-actin were to have an annealing temperature of 54°C. PCR reaction was carkidney fibroblasts (Figure 1a) . Amplification was in the exponential phase up to 36 cycles and reached saturied out at an annealing temperature of 68°C which was optimal for SERT but high for ␤-actin mRNA. Under ration at 39 cycles (Figure 2) . Therefore, in subsequent experiments 33 cycles of amplification were chosen for these conditions amplification of ␤-actin was at an exponential phase at up to 35 cycles of PCR and ampliquantitative assays. Experiments mixing 250 ng of total human brain RNA with different amounts of purified fication kinetics for SERT and ␤-actin were similar ( Figure 2) . It made it possible to estimate the abun-SERT cDNA demonstrated that the PCR assay was linear as a function of SERT amount up to 5 femtogram dance of SERT mRNA as a ratio to ␤-actin mRNA. Experiments mixing total human brain RNA with dif- (Figure 1a,b) . In order to control possible experimentto-experiment variability in efficiency of the reverse ferent amounts of purified SERT cDNA demonstrated that the PCR assay of SERT abundance as a ratio to transcription and PCR reactions, and pipetting errors, we used, as an internal control, co-amplification of ␤-actin abundance was linear over a 100-fold range (Figure 3a,b) . ␤-actin mRNA. After normalization with respect to this internal control, SERT mRNA levels in separate
In subsequent experiments all RNA samples were amplified simultaneously in the same 96-well plate samples and in different experiments can be compared directly as ratios to ␤-actin mRNA. ␤-actin is a reliable under identical conditions. Four to five independent experiments were carried out for each RNA sample. standard as its abundance did not differ in schizo- Figure 3 RT-PCR assay of SERT mRNA abundance as ratio to ␤-actin abundance. (a) PCR products from SERT and ␤-actin mRNAs separated by electrophoresis in 6% polyacrylamide gel and exposed to X-ray film. PCR was carried out with primers both for SERT and for ␤-actin mRNAs in the same tube. Lane 1, total RNA from Brodmann's area 21. Lanes 2-9, total RNA was mixed with different amounts of purified SERT fragment (starting from 0.145 femtogram and followed by two-fold increments). (b) Linearity of RT-PCR assay of SERT mRNA abundance as ratio to ␤-actin abundance. The Figure 4 Expression of SERT mRNA in the frontal and temratio between abundance of SERT and ␤-actin PCR products poral cortex of brains from controls and schizophrenics. Levwas measured after electrophoreses in 6% polyacrylamide gel els of expression are represented as arbitrary units (ratio SERT using a phosphostimulable storage plate (PhosphorImager, to ␤-actin mRNA). Values are mean ± s.e.m. 'Neuroleptic-free Molecular Dynamics). Values represent mean ± s.d. from four schizophrenics'-patients who had not been exposed to neurindependent assays. oleptics for between 2 weeks to 4.9 years prior to death. 'Neuroleptic-treated schizophrenics'-patients who had received neuroleptics within 1 week prior to death. *Denotes signifiRepeated assays of the same sample indicated a stancant difference between total schizophrenic group and condard deviation ±20% of the mean. The mean value for trol group (t = 2.46; d.f. = 22, P = 0.028). **Denotes significant each sample was used for regression analysis and for difference between total schizophrenic group and control comparison of the control and schizophrenic groups.
Expression of SERT mRNA in the frontal and temporal cortex of schizophrenics and controls istical significance (t = −1.18, d.f. = 20, P = 0.21, twotailed t-test), possibly because of the smaller number The mean level of SERT mRNA in the left frontal cortex (Brodmann's area 9) was approximately four of schizophrenic cases. times higher in schizophrenics than in controls (t = 2.46, d.f. = 22, P = 0.028, two-tailed t-test) (Figure 4) .
Effect of PMI, age and gender
Regression analysis revealed no significant correlation In contrast to the frontal cortex, the mean level of SERT mRNA in the temporal cortex of schizophrenics between SERT mRNA level and PMI in the schizophrenics (r = −0.014, F = 0.004, d.f. = 1,20, P = 0.947; was approximately two times lower than in the control group (Figure 4 (Table 1) which might influence SERT expression. Separate analysis of SERT in schizopostmortem human brain is stable within a period between 2.3 and 111 h after the death. phrenics exposed to neuroleptics only and those exposed to neuroleptics in combination with other Despite the lack of correlation in the schizophrenic and control groups, an additional analysis was perfordrugs indicated however similar changes relative to controls in both groups (data not shown). med on a subset of schizophrenic cases with the eight lowest PMI (within 11 h) matched to controls (control = 5.25 ± 2.27 min, schizophrenics 6.85 ± 2.42 min, Discussion mean ± s.d.). In this smaller subset of cases, the differences from controls were essentially the same as in the These data demonstrate region-specific differences in expression of mRNA for the serotonin transporter in total group of schizophrenics. There was a 4.6-fold increase of SERT mRNA in Brodmann's area 9 (t = brains from schizophrenic patients compared to controls. Expression of SERT mRNA in the frontal cortex 1.700, d.f. = 7.1, P = 0.135), a three-fold decrease in Brodmann's area 21 (t = −3.457, d.f. = 11.1, P = 0.006) (left superior frontal gyrus (Brodmann's area 9)) of schizophrenics was significantly increased, whereas and 1.3-fold decrease in Brodmann's area 22 (t = −0.485, d.f. = 11, P = 0.637).
expression in the temporal cortex (left middle temporal gyrus (Brodmann's area 21) and left superior temporal There were no significant correlations between SERT mRNA level and age of the donor (−0.161 ϽrϽ0.146, gyrus (Brodmann's area 22)) was significantly decreased. There was no correlation between SERT level 0.378ϽPϽ0.986). Also, no correlation was found between gender and SERT mRNA levels in any of the and the sex and age of schizophrenic and control cases or the postmortem delay intervals. three Brodmann's areas studied both when analyses were performed in the combined subject groups and From the current study it is difficult to draw a definite conclusion as to whether the changes in SERT when analyses were restricted to schizophrenic or control groups.
abundance are associated specifically with the illness itself or whether they are due to the effect of chronic neuroleptic treatment. Regression analysis indicated Effect of neuroleptic treatment Logarithmic regression analysis indicated significant logarithmic correlation between the SERT level and time without neuroleptic medication in Brodmann's negative correlation between SERT mRNA level and time without neuroleptic medication in Brodmann's area 9 and a similar trend in Brodmann's area 22. The changes in SERT mRNA level in all three regions of area 9 (r = −0.50, F = 6.60, d.f. = 1,20, P = 0.018), and a trend to positive correlation in Brodmann's area 22 brain studied were more prominent in schizophrenics who were receiving neuroleptic drugs within 1 week (r = 0.48, F = 3.25, d.f. = 1,11, P = 0.10). This indicates that there might be a difference between schizoprior to death than in schizophrenics who were neuroleptic-free for more than 2 weeks prior to death, sugphrenics who had received neuroleptic drugs shortly prior to death and those who were medication-free for gesting that the changes in SERT mRNA may be drugrelated rather than a pathophysiological effect. Notea significant period of time. Additional analysis indicated that in all three brain regions studied, the worthy, there was no correlation between the time of medication and SERT level in the group of patients changes in SERT mRNA level were more prominent in schizophrenics who had received neuroleptic drugs who had not received neuroleptics for between 2 weeks to 4.8 years prior to death. Yet still, the level of within 1 week prior to death than in schizophrenics who were free of neuroleptic drugs for more than 2 expression in this group of schizophrenics was changed as compared to controls in all three Brodweeks prior to death (Figure 4 ). The differences between schizophrenics who had received neuromann's areas studied. This could only be possible if the effect of neuroleptics has two components-a short leptics within 1 week prior to death and those who were neuroleptic-free for more than 2 weeks prior to lasting effect which disappears within the first week, and a long lasting effect which persists for many death did not reach statistical significance (t = 2.02, d.f. = 8, P = 0.13; t = −1.35, d.f. = 19, P = 0.15; and t = −1.06, months after the medication discontinues. If indeed typical neuroleptics affect expression of SERT, it may d.f. = 11, P = 0.31 for Brodmann's areas 9, 21 and 22 respectively, two-tailed t-test). There was no significant indicate a novel mechanism of their antipsychotic action. It seems unlikely that the differences in SERT difference (P = 0.3) in age between neuroleptic-treated (71 ± 3.5, range 58-87 years) and neuroleptic-'free' mRNA level between schizophrenics and controls were directly due to neuroleptic interactions with the 5-HT schizophrenics (76 ± 3.2, range 52-95 years). Male to female ratio in neuroleptic-treated schizophrenics was system. If this was a case, one would expect rather regionally uniform changes. The divergent pattern of higher (7 M/2 F) than in neuroleptic-free schizophrenics (8 M/7 F). However, when divided by gender, changes in frontal and temporal cortices would be more consistent with the indirect effect of neuroleptics differences between neuroleptic-treated schizophrenics, neuroleptic-free schizophrenics and controls were on the 5-HT system through its interaction with the dopaminergic system. Alternatively, it may be sugsimilar in males and females (data not shown).
Eleven out of 24 patients with schizophrenia had gested that the differences in SERT levels between neu-roleptic-treated and neuroleptic-'free' schizophrenics contrast to previous studies none of the patients studied here died of suicide. were not drug related but reflected differences in the The changes in SERT mRNA level in schizophrenics stage of the disease or in severity of the symptoms.
do not occur globally, but are region-specific. There is Studies on the effect of neuroleptic drugs on the SERT an approximately four-fold increase of SERT mRNA in in animals and analysis of another cohort of schizoBrodmann's area 9, and two-fold decrease in Brodphrenics would help to clarify this issue.
mann's areas 21 and 22. Therefore, abnormalities in Possible abnormalities in 5-HT uptake in schizoserotonergic neurotransmission caused by abnormaliphrenia have been previously investigated using radioties in 5-HT uptake would be expected to be regionligands that can label the 5-HT uptake sites. [8] [9] [10] [11] Analyspecific. In the frontal cortex, expression of SERT sis of [ 3 H]-paroxetine binding did not show mRNA was increased in schizophrenics, and therefore abnormalities in the frontal cortex of schizophrenics. in the presynaptic membranes leading to a decrease in slightly increased in the left hemispheres and signifi-5-HT concentration in the synaptic clefts. In the temcantly decreased in the right hemispheres from schizoporal cortex, expression of SERT mRNA was decreased phrenic brains. 8 The binding of another ligand, [ 3 H]CNin schizophrenics and therefore one could expect a IMI, was found to be decreased in the Brodmann's area decrease of 5-HT re-uptake activity and an increase of 9 and unchanged in the temporal cortex of schizosynaptic 5-HT concentration. In each particular synphrenics, 10 which is not consistent with the current apse the effect of these changes will depend on the data from the mRNA analysis. It should be noted howparticular 5-HT receptor types present in the pre-and ever, that radioligand binding and mRNA analyses deal post-synaptic membranes. A decrease of 5-HT uptake with different aspects of possible 5-HT uptake abnorin the temporal cortex would also slow down recycling malities. The changes in radioligand binding may of 5-HT into a presynaptic neuron thus compromising derive from abnormal mRNA expression, abnormal repeated firing of the neuron. translation and post-translational modifications, abnor-
The abnormal levels of SERT mRNA in schizomal protein structure and abnormal interaction of phrenia might be caused by abnormal density of sero-SERT with other components of the membrane which tonergic neurons or synapses or by abnormal regulation together with SERT form an active 5-HT uptake site.
of SERT gene expression. Analysis of mRNAs for three Considering that 5-HT uptake sites may be altered on synaptic proteins-synaptophysin, synapsin 1A and many different levels, the results of radioligand bindsynapsin 1B in the same groups of schizophrenics and ing and mRNA analysis may not necessarily correlate. controls showed that their average level of expression A complex analysis of tissue samples from the same was not changed in the schizophrenics (Sokolov et al, individuals using mRNA, protein and radioligand in preparation). Thus, the SERT abnormalities are not analysis would be most revealing.
likely to be associated with general changes in synaptic Some of the discrepancies between studies may be density. Interestingly, there is a 17-bp polymorphic explained by the relatively small sample sizes, differrepetitive element in the intron 2 of the SERT gene. ences in subject selection criteria and differences in This repeat is followed by an AP-1 motif, a putative brain region tissue sampling. For example, the [ binding site for a transcription factor comprising the paroxetine study 11 and the mRNA study (here) were heterodimer c-fos/c-jun, and therefore it has been sugcarried out on the left hemispheres, whereas the gested to play a role in the regulation of SERT gene [ 3 H]CN-IMI study was performed on the left hemiexpression. 21 The population variants in the repeat spheres from some individuals and the right or both length could contribute to differences in SERT hemispheres from others. 10 In addition, analysis of expression which may be related to vulnerability for [ In conclusion, this study, and radioligand studies Thus, combining different areas of the brain might showing changes in 5-HT uptake sites 9-11 support the compromise the conclusion.
hypothesis that regional changes in serotonin neuroAnother source of discrepancies is a difference in transmission mediated by abnormalities in 5-HT subject selection criteria. Previous 5-HT uptake studies uptake occur in brains of some schizophrenics. Further included significant numbers of patients who commitstudies on the effect of neuroleptics on the SERT in ted suicide and may have had affective components to animals and analysis of another cohort of schizotheir disease or great stress associated with their death.
phrenics with a different neuroleptic status are necesReduced concentrations of forebrain 5-HT content and sary to determine whether the changes in SERT numbers of the high-affinity 5-HT uptake sites have expression are drug or illness related. A critical subbeen reported in the brains of suicide victims. [22] [23] [24] [25] sequent study will be to determine, in the same collecNoteworthy, the change in affinity of [ 
